Your browser doesn't support javascript.
loading
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano, Mario; Schettini, Francesco; Rognoni, Carla; Milani, Manuela; Jerusalem, Guy; Bachelot, Thomas; De Laurentiis, Michelino; Thomas, Guglielmo; De Placido, Pietro; Arpino, Grazia; De Placido, Sabino; Cristofanilli, Massimo; Giordano, Antonio; Puglisi, Fabio; Pistilli, Barbara; Prat, Aleix; Del Mastro, Lucia; Venturini, Sergio; Generali, Daniele.
Afiliação
  • Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: m.giuliano@unina.it.
  • Schettini F; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Rognoni C; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italy.
  • Milani M; Breast Cancer Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.
  • Jerusalem G; Centre Hospitalier Universitaire de Liège and Liège University, Liège, Belgium.
  • Bachelot T; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France.
  • De Laurentiis M; Breast Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", Naples, Italy.
  • Thomas G; Clinica Mediterranea, Naples, Italy.
  • De Placido P; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Arpino G; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • De Placido S; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Cristofanilli M; Northwestern University, Chicago, IL, USA.
  • Giordano A; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Puglisi F; Department of Medicine, University of Udine, Udine, Italy; IRCCS Centro di Riferimento Oncologico Aviano - National Cancer Institute, Aviano, PN, Italy.
  • Pistilli B; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; SOLTI Breast Cancer Research Group, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Del Mastro L; Ospedale Policlinico San Martino-IRCCS, Genova, Italy; Department of Internal Medicine, University of Genova, Genova, Italy.
  • Venturini S; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italy; Department of Management, University of Turin, Turin, Italy.
  • Generali D; Breast Cancer Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Lancet Oncol ; 20(10): 1360-1369, 2019 10.
Article em En | MEDLINE | ID: mdl-31494037
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Hormonais Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Hormonais Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article